DK1173210T3 - Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin - Google Patents

Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin

Info

Publication number
DK1173210T3
DK1173210T3 DK00928611T DK00928611T DK1173210T3 DK 1173210 T3 DK1173210 T3 DK 1173210T3 DK 00928611 T DK00928611 T DK 00928611T DK 00928611 T DK00928611 T DK 00928611T DK 1173210 T3 DK1173210 T3 DK 1173210T3
Authority
DK
Denmark
Prior art keywords
substituted
alkyl
aminoalkyl
alkoxy
alkynyl
Prior art date
Application number
DK00928611T
Other languages
Danish (da)
English (en)
Inventor
Lin Zhi
Todd K Jones
James P Edwards
Jay E Wrobel
Gary S Grubb
Christopher M Tegley
Horace A Fletcher
Andrew Fensome
Puwen Zhang
Eugene A Terefenko
Original Assignee
Wyeth Corp
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,350 external-priority patent/US6444668B1/en
Application filed by Wyeth Corp, Ligand Pharm Inc filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK1173210T3 publication Critical patent/DK1173210T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
DK00928611T 1999-05-04 2000-05-01 Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin DK1173210T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30471299A 1999-05-04 1999-05-04
US09/552,350 US6444668B1 (en) 1999-05-04 2000-04-19 Combination regimens using progesterone receptor modulators

Publications (1)

Publication Number Publication Date
DK1173210T3 true DK1173210T3 (da) 2005-01-24

Family

ID=26974177

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00928611T DK1173210T3 (da) 1999-05-04 2000-05-01 Kontraceptive forbindelser, der indeholder et antiprogestin og et progestin

Country Status (14)

Country Link
EP (1) EP1173210B1 (cg-RX-API-DMAC10.html)
JP (1) JP2002543155A (cg-RX-API-DMAC10.html)
CN (1) CN1179753C (cg-RX-API-DMAC10.html)
AT (1) ATE275973T1 (cg-RX-API-DMAC10.html)
AU (1) AU4682000A (cg-RX-API-DMAC10.html)
CA (1) CA2372773A1 (cg-RX-API-DMAC10.html)
DE (1) DE60013798T2 (cg-RX-API-DMAC10.html)
DK (1) DK1173210T3 (cg-RX-API-DMAC10.html)
ES (1) ES2226833T3 (cg-RX-API-DMAC10.html)
HK (1) HK1043736B (cg-RX-API-DMAC10.html)
MX (1) MXPA01011311A (cg-RX-API-DMAC10.html)
PT (1) PT1173210E (cg-RX-API-DMAC10.html)
SI (1) SI1173210T1 (cg-RX-API-DMAC10.html)
WO (1) WO2000066164A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076953A1 (en) 2001-03-21 2002-10-03 Warner-Lambert Company Llc New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
AR040783A1 (es) 2002-10-11 2005-04-20 Ligand Pharm Inc 5-(1',1'-cicloaquil/alquenil) metiliden-1,2 -dihidro-5-h-cromeno [3,4- f] quiinolinas como compuestos moduladores selectivos de receptores de progesterona
TW200410968A (en) 2002-10-11 2004-07-01 Ligand Pharm Inc 5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
AR047398A1 (es) * 2003-11-24 2006-01-18 Wyeth Corp Acoplamiento cruzado carbono- carbono catalizado por metales de transicion sobre soportes solidos
BRPI0510260A (pt) * 2004-04-27 2007-10-23 Wyeth Corp método para purificar um composto, e, kit farmacêutico
WO2006023158A2 (en) 2004-07-14 2006-03-02 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds and methods, and pharmaceutical compositions containing these compounds
WO2006010142A2 (en) 2004-07-14 2006-01-26 Ligand Pharmaceuticals, Inc. Mineralocorticoid receptor modulator compounds, processes for their preparation, and their use
EP1774970A1 (de) * 2005-10-13 2007-04-18 Bayer Schering Pharma AG Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
DE4330234A1 (de) * 1993-09-02 1995-03-09 Schering Ag Verwendung von Gestagenen und kompetitiven Progesteronantagonisten zur Herstellung von Arzneimitteln für die weibliche Fertilitätskontrolle sowie Mittel enthaltend ein Gestagen und einen kompetitiven Progesteronantagonisten
DE4344463A1 (de) * 1993-12-22 1995-06-29 Schering Ag Kombinationsprodukt zur Kontrazeption
WO1996015794A1 (en) * 1994-11-22 1996-05-30 Balance Pharmaceuticals, Inc. Compositions and methods for contraception and for treatment of benign gynecological disorders
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ATE213947T1 (de) * 1996-06-25 2002-03-15 Akzo Nobel Nv Progestogen-anti-progestogen therapien

Also Published As

Publication number Publication date
CN1179753C (zh) 2004-12-15
AU4682000A (en) 2000-11-17
ES2226833T3 (es) 2005-04-01
HK1043736B (en) 2005-04-01
WO2000066164A1 (en) 2000-11-09
MXPA01011311A (es) 2003-07-14
PT1173210E (pt) 2005-01-31
DE60013798T2 (de) 2005-09-29
HK1043736A1 (en) 2002-09-27
WO2000066164A8 (en) 2001-05-03
SI1173210T1 (en) 2005-02-28
ATE275973T1 (de) 2004-10-15
DE60013798D1 (de) 2004-10-21
EP1173210A1 (en) 2002-01-23
CA2372773A1 (en) 2000-11-09
CN1349415A (zh) 2002-05-15
JP2002543155A (ja) 2002-12-17
EP1173210B1 (en) 2004-09-15

Similar Documents

Publication Publication Date Title
WO2000066165A8 (en) Contraceptive compositions containing quinazolinone and benzoxazine derivatives
DK1175398T3 (da) Indolinderivater som progesteronantagonister
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
CY1105688T1 (el) Κυανοπυρρολες ως αγωνιστες υποδοχεων προγεστερονης
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
PE20010613A1 (es) Antagonistas de la hormona concentradora de la melanina
ITRM20010356A1 (it) "5-alogeno derivati della triptamina utili come ligandi del recettore5-ht6 e/o 5-ht7 della serotonina.
WO2000066225A8 (en) Contraceptive compositions containing cyclic carbamates and amide derivatives
WO2000066103A3 (en) Contraceptive compositions containing cyclic urea and amide derivatives
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
PT1173210E (pt) Composicoes contraceptivas antiprogestativos e progestativos
BR9811769A (pt) Tetraidro gama-carbolinas
NZ515353A (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
NO992676L (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DE602005019905D1 (de) -modulatoren
DE69407807D1 (de) Indolin verbindungen und sie als aktivbestandteil enthaltende 5-ht3-antagonisten
TR200002831A2 (tr) Kinolin-4-İl türevleri I
TWI265032B (en) Pharmaceutically useful kits comprising progesterone receptor modulators
EA200101180A1 (ru) Производные тио-оксиндола
BR0010213A (pt) Derivados de ciclocarbamato como moduladores de receptor de progesterona
AR023854A1 (es) Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos
ATE412631T1 (de) Indolderivate als progesteron-rezeptormodulatoren
AR024549A1 (es) Uso de moduladores de progesterona del receptor de progesterona y kit farmaceutica para regimenes ciclicos
BG105178A (bg) Нови 2,3,3а,4,9,9а-хексахидро-8-хидрокси-1н-бенз/f/индоли, метод за получаването им и приложението им като лекарствени средства